Juvenescence has raised the first $46 million (€40 million) tranche of series B financing on route to an anticipated $100 million round. The investment, which values Juvenescence at $400 million, tees the anti-aging startup to advance the multi-asset pipeline it has built over the past 18 months toward readouts.
